Collplant Biotechnologies Ltd
NASDAQ:CLGN

Watchlist Manager
Collplant Biotechnologies Ltd Logo
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Watchlist
Price: 1.53 USD -8.38% Market Closed
Market Cap: 19.5m USD

Wall Street
Price Targets

CLGN Price Targets Summary
Collplant Biotechnologies Ltd

Wall Street analysts forecast CLGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CLGN is 11.73 USD with a low forecast of 11.11 USD and a high forecast of 12.6 USD.

Lowest
Price Target
11.11 USD
626% Upside
Average
Price Target
11.73 USD
667% Upside
Highest
Price Target
12.6 USD
724% Upside
Collplant Biotechnologies Ltd Competitors:
Price Targets
RLYB
Rallybio Corp
33% Upside
MGX
Metagenomi Inc
457% Upside
ORKA
Oruka Therapeutics Inc
65% Upside
AVCT
Avacta Group PLC
4% Upside
CYTK
Cytokinetics Inc
31% Upside
HPHA
Heidelberg Pharma AG
81% Upside
LTRN
Lantern Pharma Inc.
513% Upside
068270
Celltrion Inc
20% Upside

Revenue
Forecast

Revenue Estimate
Collplant Biotechnologies Ltd

For the last 5 years the compound annual growth rate for Collplant Biotechnologies Ltd's revenue is -26%. The projected CAGR for the next 3 years is 202%.

-26%
Past Growth
202%
Estimated Growth
Estimates Accuracy
-15%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Collplant Biotechnologies Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Net Income
Forecast

Net Income Estimate
Collplant Biotechnologies Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CLGN's stock price target?
Price Target
11.73 USD

According to Wall Street analysts, the average 1-year price target for CLGN is 11.73 USD with a low forecast of 11.11 USD and a high forecast of 12.6 USD.

What is Collplant Biotechnologies Ltd's Revenue forecast?
Projected CAGR
202%

For the last 5 years the compound annual growth rate for Collplant Biotechnologies Ltd's revenue is -26%. The projected CAGR for the next 3 years is 202%.

Back to Top